Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122700) titled 'A Single-Arm, Phase II Clinical Trial of Maintenance Therapy Combining Immunotherapy and Anti-Angiogenic Therapy in Patients with Esophageal Squamous Cell Carcinoma Who Showed No Disease Progression Following Salvage Radiotherapy and Chemotherapy for Regional Lymph Node Metastases' on April 16.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Jiangsu Cancer Hospita
Condition:
Esophagus cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-30
Target Sample Size: Single-arm Group (ESO-Nanjing17):57;
Countries of Recruitment:
China
To know mo...